This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Druggability Technologies IP Holdco Limited. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Celebrating the Innovations of Inventor Nikoletta Erdősi
Introduction: Nikoletta Erdősi, an accomplished inventor hailing from Nyiregyhaza, Hungary, has made significant contributions to the field of pharmaceuticals. With a focus on enhancing pain management, her innovative work has led to the development of two notable patents.
Latest Patents: Erdősi's latest patents revolve around a pharmaceutical composition containing Celecoxib. This formulation comprises both complexed and crystalline Celecoxib, which aims to provide fast and long-lasting continuous pain management with a once-daily dosing regimen. The improved physicochemical properties of the composition ensure a faster onset of action for acute pain relief while minimizing gastrointestinal-related side effects. Her work highlights the potential to revolutionize pain management strategies and improve the therapeutic experience for patients.
Career Highlights: Nikoletta Erdősi is associated with Druggability Technologies IP Holdco Limited, where she continues to drive innovative research in the pharmaceutical sector. Her dedication and expertise in drug formulation have positioned her as a key inventor in the field.
Collaborations: Throughout her career, Erdősi has collaborated with fellow innovators such as Richárd Balázs Kárpáti and Gergo Patyi. These partnerships have allowed her to expand the horizons of her work and contribute to impactful research and development in pharmaceuticals.
Conclusion: Nikoletta Erdősi's contributions to pharmaceutical innovations underscore her role as a significant inventor in her field. Her focus on improving pain management through innovative formulations demonstrates her commitment to advancing healthcare solutions. As she continues her work at Druggability Technologies IP Holdco Limited, her inventions are sure to pave the way for more effective treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile